Adma Biologics (ADMA) Exceeds Market Returns: Some Facts to Consider
In the closing of the recent trading day, Adma Biologics (ADMA) stood at $17.5, denoting a +1.16% move from the preceding trading day.
Is It Worth Investing in Adma Biologics (ADMA) Based on Wall Street's Bullish Views?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
ADMA Gains 13.8% in Three Months: More Upside Potential for 2026?
ADMA shares rose 13.8% over three months as demand for Asceniv surged, driving higher 2026 revenues and EBITDA targets amid margin expansion.
Adma Biologics (ADMA) Increases Despite Market Slip: Here's What You Need to Know
Adma Biologics (ADMA) concluded the recent trading session at $17.59, signifying a +1.62% move from its prior day's close.
ADMA Biologics: Business Update And My Price Target
ADMA Biologics was trading poorly in early 2021, near $2 per share. My thesis centered on ADMA's asset value, including plasma centers, matching its enterprise value. Strong revenue growth, insider buying, and a poison pill signaled management's confidence in profitability.
Adma Biologics (ADMA) Sees a More Significant Dip Than Broader Market: Some Facts to Know
In the latest trading session, Adma Biologics (ADMA) closed at $17.7, marking a -1.28% move from the previous day.
ADMA Biologics Reports Preliminary 2025 Results, Ups 2026 Outlook
ADMA expects 2025 revenues of approximately $510-$511 million, raising 2026 guidance on strong Asceniv demand and margin expansion.
Is Adma Biologics (ADMA) a Buy as Wall Street Analysts Look Optimistic?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
ADMA Biologics, Inc. (ADMA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
ADMA Biologics, Inc. (ADMA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Why Adma Biologics (ADMA) Outpaced the Stock Market Today
In the most recent trading session, Adma Biologics (ADMA) closed at $18.34, indicating a +1.72% shift from the previous trading day.
Is ADMA Biologics (ADMA) Stock Outpacing Its Medical Peers This Year?
Here is how Adma Biologics (ADMA) and Artivion (AORT) have performed compared to their sector so far this year.
Adma Biologics (ADMA) Up 43.3% Since Last Earnings Report: Can It Continue?
Adma Biologics (ADMA) reported earnings 30 days ago. What's next for the stock?
